Edition:
United Kingdom

Veracyte Inc (VCYT.OQ)

VCYT.OQ on NASDAQ Stock Exchange Global Market

5.72USD
19 Apr 2018
Change (% chg)

$0.08 (+1.42%)
Prev Close
$5.64
Open
$5.63
Day's High
$5.72
Day's Low
$5.50
Volume
730
Avg. Vol
43,620
52-wk High
$9.78
52-wk Low
$5.25

Chart for

About

Veracyte, Inc. is a genomic diagnostics company. The Company uses genomic technology to resolve diagnostic ambiguity. It targets diseases in which patients undergo invasive diagnostic procedures. Its products combine genomic technology, clinical science and machine learning. The Company commercializes over three genomic tests,... (more)

Overall

Beta: 1.62
Market Cap(Mil.): $193.40
Shares Outstanding(Mil.): 34.29
Dividend: --
Yield (%): --

Financials

  VCYT.OQ Industry Sector
P/E (TTM): -- 200.91 33.50
EPS (TTM): -0.91 -- --
ROI: -39.71 -0.75 13.17
ROE: -64.05 -2.86 14.98

BRIEF-Veracyte Announces Precision Medicine Collaboration With Loxo Oncology

* VERACYTE ANNOUNCES PRECISION MEDICINE COLLABORATION WITH LOXO ONCOLOGY

11 Apr 2018

BRIEF-Veracyte Inc Q4 Net Loss Per Common Share $0.24

* VERACYTE ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS, PROVIDES 2018 FINANCIAL OUTLOOK

27 Feb 2018

BRIEF-Veracyte Announces Strategic Realignment And New Appointments To Advance Commercial Growth

* VERACYTE ANNOUNCES STRATEGIC REALIGNMENT AND NEW APPOINTMENTS TO ADVANCE COMMERCIAL GROWTH

08 Jan 2018

BRIEF-Veracyte posts Q3 loss per share $0.21

* Q3 earnings per share view $-0.23 -- Thomson Reuters I/B/E/S

06 Nov 2017

Earnings vs. Estimates